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Table 3. Drawbacks in correlating bile and blood concentrations 
Drawback Comment 
Physiological & pharmacological  
 Variability of bile composition  Bile composition varies by site, in the fed and fasting 
state, and between individuals  
 Dosage regimen The duration, dose, and route of treatment may have 
different effects on the drug concentrations in bile and 
blood. 
 Entry of drugs into bile There is wide variability in the extent of secretion from 
drug to drug, from individual to individual, and within 
individuals at different times 
  Physicochemical properties of 
drugs 
Lipophilicity, molecular weight, and other properties may 
influence drug entry into bile 
  Transporters There is genetic heterogeneity in transporters 
  Drug-drug interactions E.g. cimetidine inhibits the biliary transport of metformin 
 Enterohepatic recirculation Relevant for several drugs and metabolites, e.g. 
amitriptyline, morphine-3-glucuronide, warfarin 
 Formation, stability, and 
pharmacokinetics of metabolites  
For example, zopiclone and nifedipine are unstable in 
biological matrices 
Pathological  
 Post-mortem interval The concentration of many drugs changes with time after 
death 
 Changes in bile and blood post-
mortem 
The composition and pH of body fluids changes after 
death 
 Post-mortem drug redistribution The concentration of drugs post mortem may differ by 
site 
 Sampling site for bile The composition of bile, and therefore drug concentration 
in bile, is different in different parts of the biliary tract 
 Sampling site for  blood There are ante-mortem concentration differences 
between arterial and venous blood, and post-mortem 
concentration differences between central (e.g. left heart) 
and peripheral (e.g. femoral) sampling sites.  
 Contamination of samples Contamination, for example, by gut content, can influence 
concentrations in blood and bile 
Analytical  
 Differences between analytical 
methods 
Results from different methods may not be comparable 
 Instability of drugs in post-mortem 
samples  
For example, zopiclone and nifedipine are unstable in 
biological matrices 
 Assays neither validated nor 
calibrated for bile 
It cannot be assumed that methods developed for blood 
will give reliable results in other matrices 
 Failure to distinguish enantiomers of 
different activities  
May misestimate biological activity, e.g. for enantiomers 
of tramadol  
 
 
 
